# ClinicalTrials.gov record NCT01507389

> PeptideScanner retained ClinicalTrials.gov record NCT01507389 at 2026-07-30T21:54:46.547Z. Its registry update date was 2014-12-09, and PeptideScanner's reviewed identity mapping was liraglutide.

- Evidence object: `story:clinicaltrials-gov-nct01507389-liraglutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2014-12-09
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01507389-liraglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01507389-liraglutide-v1.json
- Content SHA-256: `3625246d10e2d863ea4772bb1507b880d8930f12260559cf6262bfbb5800b0a7`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT01507389 ([`ctg-observation-nct01507389-2014-12-09-353803c40d60`](#source-ctg-observation-nct01507389-2014-12-09-353803c40d60))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01507389 at 2026-07-30T21:54:46.547Z. Its registry update date was 2014-12-09, and PeptideScanner's reviewed identity mapping was liraglutide. ([`ctg-observation-nct01507389-2014-12-09-353803c40d60`](#source-ctg-observation-nct01507389-2014-12-09-353803c40d60))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01507389 at 2026-07-30T21:54:46.547Z. Its registry update date was 2014-12-09, and PeptideScanner's reviewed identity mapping was liraglutide. ([`ctg-observation-nct01507389-2014-12-09-353803c40d60`](#source-ctg-observation-nct01507389-2014-12-09-353803c40d60))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01507389-2014-12-09-353803c40d60`](#source-ctg-observation-nct01507389-2014-12-09-353803c40d60))

## Sources

<a id="source-ctg-observation-nct01507389-2014-12-09-353803c40d60"></a>
- **ClinicalTrials.gov record NCT01507389 · retained source version 2014-12-09:353803c40d602451ca59d7571d02a1b457569155cad32d95d33240ec7b486e99** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01507389) (`ctg-observation-nct01507389-2014-12-09-353803c40d60`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01507389." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01507389-liraglutide-v1.json SHA-256: 3625246d10e2d863ea4772bb1507b880d8930f12260559cf6262bfbb5800b0a7.